Evidence map›Paper›PMID 37418221›Full record

Observational studySleep & breathing = Schlaf & Atmung2024

Association between undiagnosed obstructive sleep apnea and severe course of COVID-19: a prospective observational study.

Natalia Celejewska-Wójcik, Kamil Polok, Karolina Górka, Tomasz Stachura, Aleksander Kania, Paweł Nastałek, Sabina Lichołai, Weronika Zastrzeżyńska, Marek Przybyszowski, Krzysztof Sładek

Open access · hybridAbstract readObservational Study
In one paragraph

Observational study in Sleep & breathing = Schlaf & Atmung, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Observational
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Natalia Celejewska-WójcikDepartment of Pulmonology and Allergology, University Hospital, Kraków, Poland. natalia.celejewska@uj.edu.pl.ORCID 0000-0003-2770-8669
Kamil PolokDepartment of Pulmonology and Allergology, University Hospital, Kraków, Poland.
Karolina GórkaDepartment of Pulmonology and Allergology, University Hospital, Kraków, Poland.
Tomasz StachuraDepartment of Pulmonology and Allergology, University Hospital, Kraków, Poland.
Aleksander KaniaDepartment of Pulmonology and Allergology, University Hospital, Kraków, Poland.
Paweł NastałekDepartment of Pulmonology and Allergology, University Hospital, Kraków, Poland.
Sabina LichołaiDivision of Molecular Biology and Clinical Genetics, Department of Medicine, Jagiellonian University Medical College, Kraków, Poland.
Weronika ZastrzeżyńskaDepartment of Pulmonology and Allergology, University Hospital, Kraków, Poland.
Marek PrzybyszowskiDepartment of Pulmonology and Allergology, University Hospital, Kraków, Poland.
Krzysztof SładekDepartment of Pulmonology and Allergology, University Hospital, Kraków, Poland.
Jagiellonian University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeObstructive sleep apnea (OSA) is associated with many long-term health consequences. We hypothesized that previously unrecognized and untreated OSA may be associated with more severe respiratory failure in hospitalized patients with COVID-19.

methodsPatients hospitalized in the Pulmonology Department with confirmed COVID-19, University Hospital in Kraków, Poland, between September 2020 and April 2021 were enrolled. OSA screening questionnaires including Epworth Sleepiness Scale (ESS), STOP-BANG, Berlin questionaire (BQ), OSA-50, and No-SAS were completed. Polygraphy was performed after > 24 h without requirement for supplemental oxygen.

resultsOf 125 patients with median age of 61.0 years, 71% of whom were male. OSA was diagnosed in 103 patients (82%) and was categorized as mild, moderate, and severe in 41 (33%), 30 (24%), and 32 (26%), respectively. Advanced respiratory support was introduced in 85 patients (68%), and 8 (7%) patients eventually required intubation. Multivariable analysis revealed that increased risk of requirement for advanced respiratory support was associated with higher respiratory event index (OR 1.03, 95%CI 1.00 to 1.07), oxygen desaturation index (OR 1.05, 95%CI 1.02 to 1.10), and hypoxic burden (1.02 95% CI 1.00 to 1.03) and lower minimal SpO

conclusionPreviously undiagnosed OSA was common among hospitalized patients who survived the acute phase of COVID-19. The degree of OSA was associated with the severity of respiratory failure.

Indexed as

COVID-19Respiratory InsufficiencySleep Apnea, ObstructiveFemaleHumansMaleMiddle AgedOxygenProspective StudiesSurveys and QuestionnairesOxygenCOVID-19Non-invasive ventilationObstructive sleep apneaRespiratory failure

Identifiers

PMID37418221
PMCPMC10954863
OpenAlexW4383482076

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.